JMP Healthcare Ltd

JMP Healthcare Ltd
Statement of Financial Position
As at 28 February 2026

	2026		2025
	£	£	£	£
Fixed assets		0		201
Current assets	5,915		8,263
Creditors: amount falling due within one year	(5,687)		(6,040)
Net current assets		228		2,223
Total assets less current liabilities		228		2,424
Net assets		228		2,424


Capital and reserves		228		2,424

NOTES TO THE ACCOUNTS

General Information

JMP Healthcare Ltd is a private company, limited by shares, registered in England and Wales, registration number 14673389, registration address 34 Stourton Close, Sutton Coldfield, B76 2UP.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling which is the functional currency of the company.

2.	Average number of employees Average number of employees during the year was 1 (2025 : 0).

For the year ended 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The financial statements were approved by the director on 17 September 2026 and were signed by:

--------------------------------
Jake Parker
Director